Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
P & T : a peer-reviewed journal for formulary management
| P & T : a peer-reviewed journal for formulary management |
| Pubbl/distr/stampa | Yardley, PA, : MediMedia USA |
| Descrizione fisica | 1 online resource |
| Disciplina | 615 |
| Soggetto topico |
Chemotherapy
Hospitals Drug Therapy |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Pharmacy and therapeutics
Pharmacy & therapeutics P and T |
| Record Nr. | UNISA-996212077303316 |
| Yardley, PA, : MediMedia USA | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
P & T : a peer-reviewed journal for formulary management
| P & T : a peer-reviewed journal for formulary management |
| Pubbl/distr/stampa | Yardley, PA, : MediMedia USA |
| Descrizione fisica | 1 online resource |
| Disciplina | 615 |
| Soggetto topico |
Chemotherapy
Hospitals Drug Therapy |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Pharmacy and therapeutics
Pharmacy & therapeutics P and T |
| Record Nr. | UNINA-9910135263503321 |
| Yardley, PA, : MediMedia USA | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric Infectious Diseases / / editors, D. Engelhard, M.I. Marks, D. Branski
| Pediatric Infectious Diseases / / editors, D. Engelhard, M.I. Marks, D. Branski |
| Autore | Engelhard D |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1993 |
| Descrizione fisica | 1 online resource (VIII + 226 pages) : : 3 figures, 24 tables |
| Disciplina | 618.92/9 |
| Altri autori (Persone) |
EngelhardD (Dan)
MarksMelvin I BranskiD |
| Collana | Pediatric and Adolescent Medicine |
| Soggetto topico |
Pediatrics
Infectious Diseases Chemotherapy Epidemiology Immunology Neurology Parasitology Perinatal Medicine Respiratory System Urology Virology |
| ISBN | 3-318-04057-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910158688503321 |
Engelhard D
|
||
| Basel : , : S. Karger, , 1993 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Personalized cancer chemotherapy : an effective way of enhancing outcomes in clinics / / Da-Yong Lu
| Personalized cancer chemotherapy : an effective way of enhancing outcomes in clinics / / Da-Yong Lu |
| Autore | Lu Da-Yong |
| Pubbl/distr/stampa | Cambridge, England : , : Woodhead Publishing, , 2015 |
| Descrizione fisica | 1 online resource (85 p.) |
| Disciplina | 615.58 |
| Collana | Woodhead Publishing Series in Biomedicine |
| Soggetto topico |
Chemotherapy
Cancer - Treatment |
| ISBN |
0-08-101622-0
0-08-100347-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Personalized Cancer Chemotherapy: An Effective Way of Enhancing Outcomes in Clinics; Copyright; Contents; List of figures and tables; Figures; Tables; About the author; Preface; References; List of abbreviations; 1 - Introduction; References; 2 - Drug sensitivity testing; 2.1 History of drug sensitivity testing; 2.2 Methodology of drug sensitivity testing [6-7]; 2.3 Comparison between in vivo and in vitro drug sensitivity testing methodologies [6-7]; 2.4 Relationship of drug responses in drug chemosensitivity testing and clinical tumor treatment
2.5 Possible reasons for unsatisfactory survival rates in spite of using drug sensitivity testing2.6 Cytotoxic and cytostatic anti-cancer drugs?; 2.7 Conclusion; References; 3 - Individualized cancer chemotherapy via cancer biomarkers or bioinformatics detection; 3.1 Cancer biomarkers and cancer bioinformatics for ICC [1-3]; 3.2 Seeing is predicting; 3.3 New challenges; 3.4 Discussion; 3.5 Other considerations; 3.6 Mathematical modeling and computational networks as assistant systems; 3.7 Finding tumorigenic markers from the genome to predict anticancer drug responses; 3.8 Future directions References4 - Pharmacogenetics; 4.1 Background; 4.2 Introduction; 4.3 Architectural framework of an anticancer drug pharmacogenetics or pharmacogenomics study; 4.4 Examples; 4.5 Discussion; References; 5 - Individualized antimetastatic therapy [1-2]; 5.1 Background; 5.2 Will antimetastatic therapy differ from antiproliferative therapy?; 5.3 Therapeutic mechanisms of the current antimetastatic drugs; 5.4 Drawbacks of current clinical antimetastatic therapy; 5.5 Should human tumor metastasis be treated according to clinical situations -individualized antimetastatic therapy? [19,21-22]... 5.6 Find more metastatis-related molecules and develop novel types of antimetastatic drugs5.7 Targeting formed metastatic foci in clinics; 5.8 Discussion; 5.9 Conclusion; References; 6 - Drug combinations; 6.1 Introduction; 6.2 Cytotoxic drugs and biotherapy; 6.3 The advantages of a strategy of combining cytotoxic anticancer drugs and biotherapy; 6.4 Combined use of both antiproliferative drugs (primary tumor) and antimetastatic drugs; 6.5 Combined cytotoxic drugs and cytostatic drugs; 6.6 Rules of drug combination; 6.7 Conclusion; References; 7 - Assistant chemotherapy 7.1 Anti-thrombosis therapy7.2 Antidepressant therapy; 7.3 Improving patients' physiological conditions; 7.4 Conclusion; References; 8 - Cost-effectiveness considerations; 8.1 Background; 8.2 Routine cost of cancer chemotherapy; 8.3 Calculation of cost-effectiveness; 8.4 The keys to the study of cost-effectiveness in individualized cancer chemotherapy; 8.5 Future trends; 8.6 Conclusion; References; 9 - Discussion; 9.1 Drug sensitivity testing; 9.2 The development of cancer biomarker detection; 9.3 Pharmacogenetics or pharmacogenomics; 9.4 Antimetastatic therapy 9.5 Should antimetastatic drugs be offered to all cancer patients? |
| Record Nr. | UNINA-9910788201203321 |
|
Lu Da-Yong
|
||
| Cambridge, England : , : Woodhead Publishing, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Personalized cancer chemotherapy : an effective way of enhancing outcomes in clinics / / Da-Yong Lu
| Personalized cancer chemotherapy : an effective way of enhancing outcomes in clinics / / Da-Yong Lu |
| Autore | Lu Da-Yong |
| Pubbl/distr/stampa | Cambridge, England : , : Woodhead Publishing, , 2015 |
| Descrizione fisica | 1 online resource (85 p.) |
| Disciplina | 615.58 |
| Collana | Woodhead Publishing Series in Biomedicine |
| Soggetto topico |
Chemotherapy
Cancer - Treatment |
| ISBN |
0-08-101622-0
0-08-100347-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Personalized Cancer Chemotherapy: An Effective Way of Enhancing Outcomes in Clinics; Copyright; Contents; List of figures and tables; Figures; Tables; About the author; Preface; References; List of abbreviations; 1 - Introduction; References; 2 - Drug sensitivity testing; 2.1 History of drug sensitivity testing; 2.2 Methodology of drug sensitivity testing [6-7]; 2.3 Comparison between in vivo and in vitro drug sensitivity testing methodologies [6-7]; 2.4 Relationship of drug responses in drug chemosensitivity testing and clinical tumor treatment
2.5 Possible reasons for unsatisfactory survival rates in spite of using drug sensitivity testing2.6 Cytotoxic and cytostatic anti-cancer drugs?; 2.7 Conclusion; References; 3 - Individualized cancer chemotherapy via cancer biomarkers or bioinformatics detection; 3.1 Cancer biomarkers and cancer bioinformatics for ICC [1-3]; 3.2 Seeing is predicting; 3.3 New challenges; 3.4 Discussion; 3.5 Other considerations; 3.6 Mathematical modeling and computational networks as assistant systems; 3.7 Finding tumorigenic markers from the genome to predict anticancer drug responses; 3.8 Future directions References4 - Pharmacogenetics; 4.1 Background; 4.2 Introduction; 4.3 Architectural framework of an anticancer drug pharmacogenetics or pharmacogenomics study; 4.4 Examples; 4.5 Discussion; References; 5 - Individualized antimetastatic therapy [1-2]; 5.1 Background; 5.2 Will antimetastatic therapy differ from antiproliferative therapy?; 5.3 Therapeutic mechanisms of the current antimetastatic drugs; 5.4 Drawbacks of current clinical antimetastatic therapy; 5.5 Should human tumor metastasis be treated according to clinical situations -individualized antimetastatic therapy? [19,21-22]... 5.6 Find more metastatis-related molecules and develop novel types of antimetastatic drugs5.7 Targeting formed metastatic foci in clinics; 5.8 Discussion; 5.9 Conclusion; References; 6 - Drug combinations; 6.1 Introduction; 6.2 Cytotoxic drugs and biotherapy; 6.3 The advantages of a strategy of combining cytotoxic anticancer drugs and biotherapy; 6.4 Combined use of both antiproliferative drugs (primary tumor) and antimetastatic drugs; 6.5 Combined cytotoxic drugs and cytostatic drugs; 6.6 Rules of drug combination; 6.7 Conclusion; References; 7 - Assistant chemotherapy 7.1 Anti-thrombosis therapy7.2 Antidepressant therapy; 7.3 Improving patients' physiological conditions; 7.4 Conclusion; References; 8 - Cost-effectiveness considerations; 8.1 Background; 8.2 Routine cost of cancer chemotherapy; 8.3 Calculation of cost-effectiveness; 8.4 The keys to the study of cost-effectiveness in individualized cancer chemotherapy; 8.5 Future trends; 8.6 Conclusion; References; 9 - Discussion; 9.1 Drug sensitivity testing; 9.2 The development of cancer biomarker detection; 9.3 Pharmacogenetics or pharmacogenomics; 9.4 Antimetastatic therapy 9.5 Should antimetastatic drugs be offered to all cancer patients? |
| Record Nr. | UNINA-9910822907703321 |
|
Lu Da-Yong
|
||
| Cambridge, England : , : Woodhead Publishing, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacogenomics in clinical therapeutics [[electronic resource] /] / edited by Loralie J. Langman, Amitava Dasgupta
| Pharmacogenomics in clinical therapeutics [[electronic resource] /] / edited by Loralie J. Langman, Amitava Dasgupta |
| Pubbl/distr/stampa | Chichester, West Sussex, U.K., : Wiley-Blackwell, 2012 |
| Descrizione fisica | 1 online resource (256 p.) |
| Disciplina | 615.7 |
| Altri autori (Persone) |
LangmanLoralie J
DasguptaAmitava <1958-> |
| Soggetto topico |
Pharmacogenetics
Chemotherapy |
| ISBN |
1-119-95958-6
1-280-58621-4 9786613616043 1-119-95960-8 1-119-95957-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Pharmacogenomics principles : introduction to personalized medicine / Parvaz Madadi, and Gideon Koren -- Traditional therapeutic drug monitoring and pharmacogenomics : are they complementary? / Christine Snozek, Loralie J. Langman, and Amitava Dasgupta -- Pharmacogenomics aspect of warfarin therapy / Matthew D. Krasowski -- Pharmacogenetics and cancer chemotherapy / Christine L.H. Snozek -- Pharmacogenomic considerations in anesthesia and pain management / Christine Formea, Wayne T. Nicholson -- Pharmacogenomics of immunosuppressants / Nicolas Picard and Pierre Marquet -- Pharmacogenomics of cardiovascular drugs / Linnea M. Baudhuin -- Pharmacogenomics aspect of antiretroviral therapy / Natella Y. Rakhmanina and John N. van den Anker -- Pharmacogenetics of psychoactive drugs / Jorge L. Sepulveda -- Pharmacogenomic aspects of adverse drug-drug interactions / Loralie J. Langman and Christine Snozek -- Microarray technology and other methods in pharmacogenomics testing / Jorge L. Sepulveda -- Pharmacogenetic testing in the clinical laboratory environment / Mark P. Borgman and Mark W. Linder. |
| Record Nr. | UNINA-9910139697903321 |
| Chichester, West Sussex, U.K., : Wiley-Blackwell, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacokinetics of Sulfonamides Revisited / / T.B. Vree
| Pharmacokinetics of Sulfonamides Revisited / / T.B. Vree |
| Autore | Vree T.B |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1985 |
| Descrizione fisica | 1 online resource (X + 210 pages) : : 94 figures, 36 tables |
| Soggetto topico |
Pharmacology
Pharmaceutics Chemotherapy Metabolism Pharmacokinetics Veterinary Medicine |
| ISBN | 3-318-03209-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910155458703321 |
|
Vree T.B
|
||
| Basel : , : S. Karger, , 1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacology & therapeutics
| Pharmacology & therapeutics |
| Pubbl/distr/stampa | [Oxford], : Pergamon |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Pharmacology
Therapeutics Pharmacology - Periodicals Therapeutics - Periodicals Chemotherapy Drug Therapy Pharmacologie - Périodiques Thérapeutique - Périodiques Pharmacologie Thérapeutique Chimiothérapie pharmacology |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1879-016X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Pharmacology and therapeutics |
| Record Nr. | UNISA-996209588603316 |
| [Oxford], : Pergamon | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Pharmacology & therapeutics
| Pharmacology & therapeutics |
| Pubbl/distr/stampa | [Oxford], : Pergamon |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Pharmacology
Therapeutics Pharmacology - Periodicals Therapeutics - Periodicals Chemotherapy Drug Therapy Pharmacologie - Périodiques Thérapeutique - Périodiques Pharmacologie Thérapeutique Chimiothérapie pharmacology |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1879-016X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Pharmacology and therapeutics |
| Record Nr. | UNINA-9910145489503321 |
| [Oxford], : Pergamon | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacotherapeutics for advanced practice : a practical approach / / editors, Virginia P. Arcangelo [and three others]
| Pharmacotherapeutics for advanced practice : a practical approach / / editors, Virginia P. Arcangelo [and three others] |
| Edizione | [Fourth edition.] |
| Pubbl/distr/stampa | Philadelphia, [Pennsylvania] : , : Wolters Kluwer, , 2017 |
| Descrizione fisica | 1 online resource (1,982 pages) : illustrations |
| Disciplina | 615.5/8 |
| Soggetto topico |
Chemotherapy
Drug Therapy Pharmacologic Actions |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-4963-5184-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910511315603321 |
| Philadelphia, [Pennsylvania] : , : Wolters Kluwer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Chemotherapy
(193)
- Drug Therapy (69)
- Pharmacology (60)
- Chimiothérapie (43)
- Oncology (40)